HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

about

Treating HIV Infection in the Central Nervous System.

P2860

Q39077816-FE568E62-F179-4C30-AF26-311717F4B524

P2860

HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

Item

http://www.wikidata.org/entity/Q38952927

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

@en

type

Item

label

HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

@en

prefLabel

HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

@en

P1476

HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

@en

P2093

Alan Winston

http://www.w3.org/2001/XMLSchema#string

Borja Mora-Peris

http://www.w3.org/2001/XMLSchema#string

Carolina Herrera

http://www.w3.org/2001/XMLSchema#string

Laura J Else

http://www.w3.org/2001/XMLSchema#string

Lucy Garvey

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature

Researchers buoyed by novel HIV drugs: will expand drug arsenal against resistant virus

Access denied? The status of co-receptor inhibition to counter HIV entry

Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype

A constrained least-squares approach to the automated quantitation of in vivo ¹H magnetic resonance spectroscopy data.

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

P304

235-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKV326

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robin Shattock

P577

2015-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26472771

http://www.w3.org/2001/XMLSchema#string

P932

5890655

http://www.w3.org/2001/XMLSchema#string

HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

about

P2860

P2860

HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932